{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:27:39Z","timestamp":1787315259574,"version":"build-2736575974"},"reference-count":35,"publisher":"Walter de Gruyter GmbH","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jbcpp-2015-0054_s_999_w2aab2b8b6b1b7b1aab1c14b1Aa\">\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      This study was conducted to determine the antioxidant and acetylcholinesterase inhibitory activities of the leaf extract and different fractions of\n                      <jats:italic>Albizia adianthifolia<\/jats:italic>\n                      (Schumach.) W. Wright, and also to identify and quantify some phenolic compounds in the extract.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jbcpp-2015-0054_s_998_w2aab2b8b6b1b7b1aab1c14b2Aa\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      The antioxidant and acetylcholinesterase inhibitory activities of the methanol extract (CME), ethyl acetate (EAF), chloroform (CHF), and\n                      <jats:italic>n<\/jats:italic>\n                      -hexane (NHF) fractions of\n                      <jats:italic>A. adianthifolia<\/jats:italic>\n                      leaves were subjected to in vitro chemical analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jbcpp-2015-0054_s_997_w2aab2b8b6b1b7b1aab1c14b3Aa\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Phytochemical screening revealed important classes of secondary metabolites. All extracts showed good antioxidant and acetylcholinesterase inhibitory activities. The EAF and CHF gave the highest total phenolic contents of 18.02\u00b10.14 and 18.43\u00b10.95 mg gallic acid equivalent per gram of extract, respectively. The polar extracts gave the highest activity in both assays with lower IC\n                      <jats:sub>50<\/jats:sub>\n                      values. In the 2,2-diphenyl-1-picrylhydrazyl free-radical scavenging activity assay, the IC\n                      <jats:sub>50<\/jats:sub>\n                      values of CME, EAF, CHF, and NHF were 77.74\u00b10.84, 55.76\u00b12.30, 58.47\u00b10.72, and 232.24\u00b12.70 \u00b5g\/mL, respectively, while in the acetylcholinesterase inhibitory assay, the IC\n                      <jats:sub>50<\/jats:sub>\n                      values of CME, EAF, CHF, and NHF were 11.80\u00b10.88, 10.04\u00b11.67, 17.44\u00b11.74, and 124.38\u00b11.51 \u00b5g\/mL, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jbcpp-2015-0054_s_996_w2aab2b8b6b1b7b1aab1c14b4Aa\">\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      The results of this study suggest that the leaf of\n                      <jats:italic>A. adianthifolia<\/jats:italic>\n                      could serve as a potential candidate for future search of antioxidant and acetylcholinesterase inhibitors for the management of neurodegenerative disorders such as Alzheimer\u2019s disease.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jbcpp-2015-0054","type":"journal-article","created":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T08:58:06Z","timestamp":1474534686000},"page":"143-148","source":"Crossref","is-referenced-by-count":15,"title":["Antioxidant and acetylcholinesterase inhibitory activities of leaf extract and fractions of\n                    <i>Albizia adianthifolia<\/i>\n                    (Schumach) W.F. Wright"],"prefix":"10.1515","volume":"28","author":[{"given":"Mubo A.","family":"Sonibare","sequence":"first","affiliation":[{"name":"Department of Pharmacognosy, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria , Phone: +2348134901273, E-mail:"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibukun O.","family":"Ayoola","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiwo O.","family":"Elufioye","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2016,9,22]]},"reference":[{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_001_w2aab2b8b6b1b7b1ab2b1b1Aa","doi-asserted-by":"crossref","unstructured":"Patocka J, Kuca K, Jun D. Acetylcholinesterase: crucial enzyme of human body. Acta Med (Hradec Kralove) 2004;47:215\u201330.","DOI":"10.14712\/18059694.2018.95"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_002_w2aab2b8b6b1b7b1ab2b1b2Aa","unstructured":"Alzheimer\u2019s Association. Alzheimer\u2019s disease facts and figures. J Alzheimers Dement 2012;8:131\u201368."},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_003_w2aab2b8b6b1b7b1ab2b1b3Aa","doi-asserted-by":"crossref","unstructured":"Shah RS, Lee HG, Xiongwei Z, Perry G, Smith MA, Castellani RJ. Current approaches in the treatment of Alzheimer\u2019s disease. Biomed Pharmacother 2008;62:199\u2013207.","DOI":"10.1016\/j.biopha.2008.02.005"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_004_w2aab2b8b6b1b7b1ab2b1b4Aa","doi-asserted-by":"crossref","unstructured":"R\u00f6sler M, Anand R, Cicin-Sain A, Gauthier S, Agid Y, Dal-bianco P, et al. Efficacy and safety of rivastigmine in patients with Alzheimer\u2019s disease: international randomized controlled trial. Br Med J 1999;318:633\u201340.","DOI":"10.1136\/bmj.318.7184.633"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_005_w2aab2b8b6b1b7b1ab2b1b5Aa","unstructured":"Brenner GM. Pharmacology. Philadelphia: Saunders, 2000."},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_006_w2aab2b8b6b1b7b1ab2b1b6Aa","doi-asserted-by":"crossref","unstructured":"Rahman AU, Choudhary MI. Bioactive natural products as a potential source of new pharmacophores a theory of memory. Pure Appl Chem 2001;73:555\u201360.","DOI":"10.1351\/pac200173030555"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_007_w2aab2b8b6b1b7b1ab2b1b7Aa","doi-asserted-by":"crossref","unstructured":"Elufioye TO, Obuotor EM, Sennuga AT, Agbedahunsi JM, Adesanya SA. Acetylcholinesterase and butyrylcholinesterase inhibitory activity of some selected Nigerian medicinal plants. Braz J Pharmacog 2010;20:472\u20137.","DOI":"10.1590\/S0102-695X2010000400002"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_008_w2aab2b8b6b1b7b1ab2b1b8Aa","doi-asserted-by":"crossref","unstructured":"Oh MH, Houghton PJ, Whang WK, Cho JH. Screening of Korean herbal medicines used to improve cognitive function for anticholinesterase activity. Phytomedicine 2004;11:544\u20138.","DOI":"10.1016\/j.phymed.2004.03.001"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_009_w2aab2b8b6b1b7b1ab2b1b9Aa","doi-asserted-by":"crossref","unstructured":"Winblad BB, Cummings J, Andreasen N, Grossberg G, Onofrj M, Sadowsky C, et al. A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer\u2019s disease\u2013rivastigmine patch versus capsule. Int J Geriatr Psychiat 2007;22:456\u201367.","DOI":"10.1002\/gps.1788"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_010_w2aab2b8b6b1b7b1ab2b1c10Aa","doi-asserted-by":"crossref","unstructured":"Wentrup A, Oertel WH, Dodel R. Once-daily transdermal rivastigmine in the treatment of Alzheimer\u2019s disease. Drug Des Devel Ther 2008;2:245\u201354.","DOI":"10.2147\/DDDT.S3102"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_011_w2aab2b8b6b1b7b1ab2b1c11Aa","doi-asserted-by":"crossref","unstructured":"Stegmark R, Akesson B. Total antioxidant capacity in different pea (Pisum sativum) varieties after blanching and freezing. Food Chem 2004,86:501\u20137.","DOI":"10.1016\/j.foodchem.2003.09.002"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_012_w2aab2b8b6b1b7b1ab2b1c12Aa","doi-asserted-by":"crossref","unstructured":"Madsen HL, Bertelsen G. Spices as antioxidants. Trends Food Sci Technol 1995;6:271\u20137.","DOI":"10.1016\/S0924-2244(00)89112-8"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_013_w2aab2b8b6b1b7b1ab2b1c13Aa","unstructured":"Zabala NQ. Albizia and Paraserianthes species. Surigao del Sur, Philippines: Proceedings of an international workshop held in Bisli, 1997;13\u20139."},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_014_w2aab2b8b6b1b7b1ab2b1c14Aa","doi-asserted-by":"crossref","unstructured":"Khanna D, Sethi G, Ahn KS, Pandey MK, Kunnumakkara AB, Sung B, et al. Natural products as a gold mine for arthritis treatment. Opin Pharmacol 2007;7:344\u201351.","DOI":"10.1016\/j.coph.2007.03.002"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_015_w2aab2b8b6b1b7b1ab2b1c15Aa","unstructured":"Fusco D, Colloca G, Lo Monaco MR, Cesari M. Effects of antioxidant supplementation on the aging process. Clin Interven Aging 2007;2:377\u201387."},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_016_w2aab2b8b6b1b7b1ab2b1c16Aa","unstructured":"Trease GE, Evans WC. Trease & Evans\u2019 pharmacognosy, 13th ed. London: Bailliere Tindale, 1989:832."},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_017_w2aab2b8b6b1b7b1ab2b1c17Aa","unstructured":"Eleazu CO, Eleazu KC, Awa E, Chukwuma SC. Comparative study of the phytochemical composition of the leaves of five Nigerian medicinal plants. J Biotechnol Pharm Res 2012;3:42\u20136."},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_018_w2aab2b8b6b1b7b1ab2b1c18Aa","doi-asserted-by":"crossref","unstructured":"Khatoon M, Islam E, Islam R, Abdur Rahman A, Alam K. Estimation of total phenol and in vitro antioxidant activity of Albizia procera leaves. BMC Res Notes 2013;6:121\u20137.","DOI":"10.1186\/1756-0500-6-121"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_019_w2aab2b8b6b1b7b1ab2b1c19Aa","unstructured":"Ebrahimzadeh MA, Nabavi SM, Nabavi SF, Eslami B. Antioxidant and Antihemolytic potentials of Physospermum cornobiense (L.) DC. Pharmacologyonline 2009;1:1318\u201323."},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_020_w2aab2b8b6b1b7b1ab2b1c20Aa","doi-asserted-by":"crossref","unstructured":"Susanti D, Sirat HM, Ahmad F, Ali RM, Aimi N. Antioxidant and cytotoxic flavonoids from the flowers of Melastoma malabathricum L. Food Chem 2007;103:710\u20136.","DOI":"10.1016\/j.foodchem.2006.09.011"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_021_w2aab2b8b6b1b7b1ab2b1c21Aa","doi-asserted-by":"crossref","unstructured":"Eldeen IM, Elgarashi EE, Van-Staden J. Antibacterial, anti-inflammatory, anti-cholinesterase and mutagenic effects of extracts obtained from some trees used in South African traditional medicine. J Ethnopharmacol 2005;102:457\u201364.","DOI":"10.1016\/j.jep.2005.08.049"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_022_w2aab2b8b6b1b7b1ab2b1c22Aa","doi-asserted-by":"crossref","unstructured":"Mahomoodally MF, Gurib-Fakim A, Subratty AH. Antimicrobial activities and phytochemical profiles of endemic medicinal plants of Mauritius. Pharmaceut Biol 2005;43:237\u201342.","DOI":"10.1080\/13880200590928825"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_023_w2aab2b8b6b1b7b1ab2b1c23Aa","doi-asserted-by":"crossref","unstructured":"Robards K, Prenzler PD, Tucker G, Swatsitang P, Glover W. Phenolic compounds and their role in oxidative processes in fruits. Food Chem 1999;66:401\u201336.","DOI":"10.1016\/S0308-8146(99)00093-X"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_024_w2aab2b8b6b1b7b1ab2b1c24Aa","doi-asserted-by":"crossref","unstructured":"Hakkim FL, Shankar CG, Girija S. Chemical composition and antioxidant property of holy basil (Ocimum sanctum L.) leaves, stems and inflorescence and their in vitro callus cultures. J Agric Food Chem 2007;55:9109\u201317.","DOI":"10.1021\/jf071509h"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_025_w2aab2b8b6b1b7b1ab2b1c25Aa","doi-asserted-by":"crossref","unstructured":"Shahidi F, Wanasundara PK. Phenolic antioxidants. Crit Rev Food Sci Nutr 1992;32:67\u2013103.","DOI":"10.1080\/10408399209527581"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_026_w2aab2b8b6b1b7b1ab2b1c26Aa","doi-asserted-by":"crossref","unstructured":"Kumar S, Mishra A, Pandey AK. Antioxidant mediated protective effect of Parthenium hysterophorus against oxidative damage using in vitro models. BMC Compl Altern Med 2013;13:120.","DOI":"10.1186\/1472-6882-13-120"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_027_w2aab2b8b6b1b7b1ab2b1c27Aa","doi-asserted-by":"crossref","unstructured":"Marksberry WR, Lovell MA. Damage to lipids, proteins, DNA and RNA in mild cognitive impairment. Arch Neurol 2007;64:954\u20136.","DOI":"10.1001\/archneur.64.7.954"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_028_w2aab2b8b6b1b7b1ab2b1c28Aa","doi-asserted-by":"crossref","unstructured":"Scarpini E, Schelterns P, Feldman H. Treatment of Alzheimer\u2019s disease; current status and new perspectives. Lancet Neurol 2003;2:539\u201347.","DOI":"10.1016\/S1474-4422(03)00502-7"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_029_w2aab2b8b6b1b7b1ab2b1c29Aa","doi-asserted-by":"crossref","unstructured":"Mukherjee PK, Kumar V, Houghton PJ. Screening of Indian medicinal plants for acetylcholinesterase inhibitory activity. Phytother Res 2007;21:1142\u20135.","DOI":"10.1002\/ptr.2224"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_030_w2aab2b8b6b1b7b1ab2b1c30Aa","doi-asserted-by":"crossref","unstructured":"Dohi S, Terasaki M, Makino M. Acetylcholinesterase inhibitory activity and chemical composition of commercial essential oils. J Agric Food Chem 2009;57:4313\u20138.","DOI":"10.1021\/jf804013j"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_031_w2aab2b8b6b1b7b1ab2b1c31Aa","doi-asserted-by":"crossref","unstructured":"Ademosun AO, Oboh G. Inhibition of acetylcholinesterase activity and Fe2+-induced lipid peroxidation in rat brain in vitro by some citrus fruit juices. J Med Food 2012;15:1\u20137.","DOI":"10.1089\/jmf.2011.0226"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_032_w2aab2b8b6b1b7b1ab2b1c32Aa","doi-asserted-by":"crossref","unstructured":"Odubanjo VO, Oboh G, Ibukun OE. Antioxidant and anticholinesterase activities of aqueous extract of Uraria picta (Jacq.) DC. Afr J Pharm Pharmacol 2013;7:2768\u201373.","DOI":"10.5897\/AJPP2013.3899"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_033_w2aab2b8b6b1b7b1ab2b1c33Aa","doi-asserted-by":"crossref","unstructured":"Zandi PP, Anthony JC, Khachaturian AS, Stone SV, Gustafson D, Tschanz JT, et al. Reduced risk of Alzheimer\u2019s disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol 2004;61:82\u20138.","DOI":"10.1001\/archneur.61.1.82"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_034_w2aab2b8b6b1b7b1ab2b1c34Aa","doi-asserted-by":"crossref","unstructured":"Ramassamy C. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur J Pharmacol 2006;545:51\u201364.","DOI":"10.1016\/j.ejphar.2006.06.025"},{"key":"2025121209161584162_j_jbcpp-2015-0054_ref_035_w2aab2b8b6b1b7b1ab2b1c35Aa","doi-asserted-by":"crossref","unstructured":"Asaduzzaman M, Uddin MJ, Kader MA, Alam AH, Rahman AA, Rashid M, et al. In vitro acetylcholinesterase inhibitory activity and the antioxidant properties of Aegle marmelos leaf extract: implications for the treatment of Alzheimer\u2019s disease. Psychogeriatrics 2014;14:1\u201310.","DOI":"10.1111\/psyg.12031"}],"container-title":["Journal of Basic and Clinical Physiology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/jbcpp.2017.28.issue-2\/jbcpp-2015-0054\/jbcpp-2015-0054.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2015-0054\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2015-0054\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:56:12Z","timestamp":1765540572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2015-0054\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,22]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,9,22]]},"published-print":{"date-parts":[[2017,3,1]]}},"alternative-id":["10.1515\/jbcpp-2015-0054"],"URL":"https:\/\/doi.org\/10.1515\/jbcpp-2015-0054","relation":{},"ISSN":["2191-0286","0792-6855"],"issn-type":[{"value":"2191-0286","type":"electronic"},{"value":"0792-6855","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9,22]]}}}